Cargando…

Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride

The aim of the present research was to develop a bilayer tablet of venlafaxine hydrochloride for bimodal drug release. In the present investigation authors have tried to explore fenugreek mucilage (FNM) for bioadhesive sustained release layer. The attempt has been made to combine FNM with well studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Momin, Munira M., Kane, Snehal, Abhang, Pooja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496574/
https://www.ncbi.nlm.nih.gov/pubmed/26217229
http://dx.doi.org/10.3389/fphar.2015.00144
_version_ 1782380428590579712
author Momin, Munira M.
Kane, Snehal
Abhang, Pooja
author_facet Momin, Munira M.
Kane, Snehal
Abhang, Pooja
author_sort Momin, Munira M.
collection PubMed
description The aim of the present research was to develop a bilayer tablet of venlafaxine hydrochloride for bimodal drug release. In the present investigation authors have tried to explore fenugreek mucilage (FNM) for bioadhesive sustained release layer. The attempt has been made to combine FNM with well studied bioadhesive polymers like hydroxy propyl methyl cellulose (HPMC), Carbopol, and Xanthan Gum. The formulations were evaluated for swelling Index, ex vivo bioadhesion, water uptake studies, in vitro drug release and dissolution kinetics was studied. Substantial bioadhesion force (2.4 ± 0.023 g) and tablet adhesion retention time (24 ± 2 h) was observed with FNM and HPMC combination at 80:20 ratio. The dissolution kinetics followed the Higuchi model (R(2) = 0.9913) via a non-Fickian diffusion controlled release mechanism after the initial burst. The 3(2) full factorial design was employed in the present study. The type of polymers used in combination with FNM (X1) and percent polymer replaced with FNM (X2) were taken as independent formulations variables. The selected responses, bioadhesion force (0.11–0.25 ± 0.023 g), amount of drug released in 10 h, Y(10) (78.20–95.78 ± 1.24%) and bioadhesive strength, (19–24 ± 2 h) presented good correlation with the selected independent variables. Statistical analysis (ANOVA) of the optimized bilayer formulations showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.05) in the amount of drug released after 1 hr till 12 h from optimized formulations was observed. The natural mucilage like FNM could be successfully incorporated into tablet with only 20% replacement with HPMC and it showed good bioadhesiveness and sustained drug release.
format Online
Article
Text
id pubmed-4496574
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-44965742015-07-27 Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride Momin, Munira M. Kane, Snehal Abhang, Pooja Front Pharmacol Pharmacology The aim of the present research was to develop a bilayer tablet of venlafaxine hydrochloride for bimodal drug release. In the present investigation authors have tried to explore fenugreek mucilage (FNM) for bioadhesive sustained release layer. The attempt has been made to combine FNM with well studied bioadhesive polymers like hydroxy propyl methyl cellulose (HPMC), Carbopol, and Xanthan Gum. The formulations were evaluated for swelling Index, ex vivo bioadhesion, water uptake studies, in vitro drug release and dissolution kinetics was studied. Substantial bioadhesion force (2.4 ± 0.023 g) and tablet adhesion retention time (24 ± 2 h) was observed with FNM and HPMC combination at 80:20 ratio. The dissolution kinetics followed the Higuchi model (R(2) = 0.9913) via a non-Fickian diffusion controlled release mechanism after the initial burst. The 3(2) full factorial design was employed in the present study. The type of polymers used in combination with FNM (X1) and percent polymer replaced with FNM (X2) were taken as independent formulations variables. The selected responses, bioadhesion force (0.11–0.25 ± 0.023 g), amount of drug released in 10 h, Y(10) (78.20–95.78 ± 1.24%) and bioadhesive strength, (19–24 ± 2 h) presented good correlation with the selected independent variables. Statistical analysis (ANOVA) of the optimized bilayer formulations showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.05) in the amount of drug released after 1 hr till 12 h from optimized formulations was observed. The natural mucilage like FNM could be successfully incorporated into tablet with only 20% replacement with HPMC and it showed good bioadhesiveness and sustained drug release. Frontiers Media S.A. 2015-07-09 /pmc/articles/PMC4496574/ /pubmed/26217229 http://dx.doi.org/10.3389/fphar.2015.00144 Text en Copyright © 2015 Momin, Kane and Abhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Momin, Munira M.
Kane, Snehal
Abhang, Pooja
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title_full Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title_fullStr Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title_full_unstemmed Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title_short Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
title_sort formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496574/
https://www.ncbi.nlm.nih.gov/pubmed/26217229
http://dx.doi.org/10.3389/fphar.2015.00144
work_keys_str_mv AT mominmuniram formulationandevaluationofbilayertabletforbimodalreleaseofvenlafaxinehydrochloride
AT kanesnehal formulationandevaluationofbilayertabletforbimodalreleaseofvenlafaxinehydrochloride
AT abhangpooja formulationandevaluationofbilayertabletforbimodalreleaseofvenlafaxinehydrochloride